CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: Evidence from a meta-analysis

Molecular Biology Reports

Volumn 40, Issue 5, 2013, Pages 3483-3491

  Ding, Gang ^a,b   Xu, Weiguo ^a   Liu, Hedai ^a   Zhang, Ming ^a   Huang, Qian ^a   Liao, Zhijun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Institute of Chongming Xinhua Cancer Research   (China)

Author keywords

CYP1A1 MspI; Meta analysis; Polymorphisms; Prostate cancer

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A1 MSPI; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROSTATE CANCER; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; PUBLICATION BIAS;

EID: 84878404358     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2423-0     Document Type: Article

References (45)

1. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61:1079-1092
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
3. Alptekin D, Izmirli M, Bayazit Y, Luleyap HU, Yilmaz MB et al (2012) Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer. Genet Mol Res 11:1424-1432
4. Hosseini M, SeyedAlinaghi S, Mahmoudi M, McFarland W (2010) A case-control study of risk factors for prostate cancer in Iran. Acta Med Iran 48:61-66
5. Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS et al (1999) Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 80:699-703
6. Keshava C, McCanlies EC, Weston A (2004) CYP3A4 polymorphisms. Potential risk factors for breast and prostate cancer: a HuGE review. Am J Epidemiol 160:825-841
7. Qadri Q, Sameer AS, Shah ZA, Hamid A, Alam S et al (2011) Genetic polymorphism of the glutathione-S-transferase P1 gene (GSTP1) and susceptibility to prostate cancer in the Kashmiri population. Genet Mol Res 10:3038-3045
8. Zhang H, Xu Y, Li L, Liu R, Ma B (2012) The interleukin-6-174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis. Urol Int 88:447-453
9. Zhang WB, Zhang JH, Pan ZQ, Yang QS, Liu B (2012) The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7,306 cases and 8,062 controls. Asian Pac J Cancer Prev 13:2597-2604
10. Guengerich FP, Shimada T (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 400:201-213
11. Zhou SF, Liu JP, Chowbay B (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41:89-295
12. Juarez-Cedillo T, Vallejo M, Fragoso JM, Hernandez-Hernandez DM, Rodriguez-Perez JM et al (2007) The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism. Eur J Cancer 43:1590-1595
13. Shin A, Kang D, Choi JY, Lee KM, Park SK et al (2007) Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Exp Mol Med 39:361-366
14. Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK (2011) CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res 30:99
15. Shaik AP, Jamil K, Das P (2009) CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J 6:78-86
16. Gao JP, Huang YD, Yang GZ, Yang YQ (2003) Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer. Zhonghua Nan Ke Xue 9:32-35
17. Mittal RD, Srivastava DL (2007) Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA Cell Biol 26:791-798
18. Souiden Y, Mahdouani M, Chaieb K, Bakhrouf A, Mahdouani K (2012) Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men. Genet Test Mol Biomarkers 16:661-666
19. Salanti G, Amountza G, Ntzani EE, Ioannidis JP (2005) Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 13:840-848
20. Cochran WG (1950) The comparison of percentages in matched samples. Biometrika 37:256-266
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560
22. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
23. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
24. Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21:1559-1573
25. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15-17
26. Stuck AE, Rubenstein LZ, Wieland D (1998) Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 316:469; author reply 470-461
27. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
28. Caceres DD, Iturrieta J, Acevedo C, Huidobro C, Varela N et al (2005) Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions. Eur J Epidemiol 20:79-88
29. Chang BL, Zheng SL, Isaacs SD, Turner A, Hawkins GA et al (2003) Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer 106:375-378
30. Guan TY, Li M, Na YQ (2005) Polymorphism of metabolic gene and genetic susceptibility to prostate cancer. Zhonghua Wai Ke Za Zhi 43:1467-1470
31. Holt SK, Kwon EM, Fu R, Kolb S, Feng Z et al (2012) Association of variants in estrogen-related pathway genes with prostate cancer risk. Prostate 73(1):1-10
32. Kumar V, Yadav CS, Singh S, Goel S, Ahmed RS et al (2010) CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer. Chemosphere 81:464-468
33. Li M, Guan TY, Li Y, Na YQ (2008) Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chin Med J (Engl) 121:305-308
34. Lima MM Jr, Oliveira MN, Granja F, Trindade AC, De Castro Santos LE et al (2008) Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients. Folia Biol (Praha) 54:102-108
35. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H et al (2001) Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione-S- transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165:171-177
36. Quinones LA, Irarrazabal CE, Rojas CR, Orellana CE, Acevedo C et al (2006) Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J Androl 8:349-355
37. Suzuki K, Matsui H, Nakazato H, Koike H, Okugi H et al (2003) Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study. Cancer Lett 195:177-183
38. Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, Jayanth VR et al (2005) Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer. Cancer Biomark 1:251-258
39. Wu YJ, Liang CH, Zhou FJ, Gao X, Chen LW et al (2009) A case-control study of environmental and genetic factors and prostate cancer in Guangdong. Zhonghua Yu Fang Yi Xue Za Zhi 43:581-585
40. Yang J, Qian LX, Wu HF, Xu ZQ, Sui YG et al (2006) Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China. Int J Urol 13:773-780
41. Kumar V, Singh S, Yadav CS, Ahmed RS, Gupta S et al (2010) CYP1A1 and CYP3A4 polymorphic variations in Delhi population of Northern India. Environ Toxicol Pharmacol 29:126-130
42. Zhuo W, Zhang L, Wang Y, Zhu B, Chen Z (2012) CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5,018 subjects. J Exp Clin Cancer Res 31:62
43. Guo R, Guo X (2012) Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk. Tumour Biol 33:1125-1132
44. Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF (2011) Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis. Int J Gynecol Cancer 21:323-331
45. Zheng Y, Wang JJ, Sun L, Li HL (2012) Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep 39:3533-3540